Foundayo vs Zepbound: Pill vs Injection, Results, Cost, and Who Each Fits

Foundayo and Zepbound are both made by Eli Lilly. Both help with weight loss. But they are completely different drugs with different tradeoffs.

Foundayo is a daily pill. Zepbound is a weekly injection. One targets GLP-1. The other targets GLP-1 and GIP. The weight loss numbers are different. The side effects overlap but are not identical. The cost is similar on paper but can vary widely depending on your insurance.

Here is how they compare — and how to think about which one might fit you.

Important: No head-to-head trial between Foundayo and Zepbound has ever been conducted. All weight loss numbers below come from separate studies with different patient groups. You cannot directly compare them. Treat cross-trial numbers as approximate, not as proof that one drug is stronger than the other.

Foundayo vs Zepbound at a Glance

Feature	Foundayo	Zepbound
Active ingredient	Orforglipron	Tirzepatide
Mechanism	GLP-1 receptor agonist	GLP-1/GIP dual agonist
How you take it	Daily pill	Weekly injection
Needles	No	Yes
Food/water rules	None	None
FDA approval	Weight management (April 2026)	Weight management (November 2023)
Maker	Eli Lilly	Eli Lilly
Avg weight loss (separate trials)	~11% over 72 weeks	~20% over 72 weeks
Max dose	17.2 mg daily	15 mg weekly
Approx list price	~$1,050/month	~$1,060/month

Remember: the weight loss numbers above come from separate clinical trials. They are not directly comparable.

How They Work

Both medications affect the GLP-1 hormone pathway, but they do not work the same way.

Foundayo (orforglipron) is a GLP-1 receptor agonist. It mimics one hormone — GLP-1 — which helps you feel full, slows digestion, and controls blood sugar. Foundayo is a non-peptide molecule, which is why it can be absorbed as a pill without the strict food and water rules that other oral GLP-1s require.

Zepbound (tirzepatide) is a GLP-1/GIP dual agonist. It targets two hormones — GLP-1 and GIP. The extra GIP pathway may explain why tirzepatide produces more weight loss in trials than GLP-1-only medications. Zepbound is a peptide, which is why it currently requires injection. See our tirzepatide guide for more on how dual agonism works.

The key difference: Foundayo works on one hormone pathway. Zepbound works on two. That does not automatically make Zepbound better for every person, but it does explain the stronger average weight loss results seen in separate trials.

Weight Loss Results Compared

No head-to-head trial exists. Here is what each drug showed in its own studies:

Foundayo (ACHIEVE-1 trial, published NEJM April 2025):

~11% average body weight loss over 72 weeks at the 17.2 mg dose
Combined with diet and exercise counseling
Placebo group lost ~5%

Zepbound (SURPASS-2 and SURMOUNT-1 trials):

~20-22% average body weight loss over 72 weeks at the 15 mg dose
Combined with diet and exercise counseling
Placebo group lost ~3-5%

These are separate trials with different patient populations, different inclusion criteria, and different endpoints. The numbers cannot be directly compared. What you can say:

Both medications produced meaningful weight loss in their respective trials
Both outperformed placebo
Zepbound's results were numerically larger, but the studies were not designed to test one against the other

For a broader comparison of GLP-1 weight loss results, see our best GLP-1 for weight loss guide.

Pill Convenience vs Weekly Injection

This is where the real decision lives for many people.

Foundayo: Daily Pill

Take one pill each day, any time
No food restrictions — take with or without food
No water timing rules — drink any amount
No needles, no injection supplies
Fits into an existing daily routine (like taking a vitamin)
Risk: easier to miss a single dose, though missing one day is less disruptive than missing a weekly injection

A daily pill organizer can help you stay on track with Foundayo.

Zepbound: Weekly Injection

One injection per week, same day each week
Inject into stomach, thigh, or upper arm
No food rules around injection time
Requires needle supplies and refrigeration
Risk: if you miss a weekly dose, you lose a full week of medication coverage

If you choose Zepbound, you will need alcohol prep pads, a sharps container for safe disposal, and possibly a travel cooler if you take trips. GLPSpot may earn from qualifying purchases.

Which Routine Fits You?

Choose Foundayo if you hate needles, want zero food rules, or prefer a daily habit over a weekly appointment with yourself
Choose Zepbound if you prefer fewer doses per week, are comfortable with injections, or travel often and want fewer doses to manage

Neither approach is wrong. The best routine is the one you will actually follow consistently.

Side Effects Compared

Both medications cause similar gastrointestinal side effects. The rates are not directly comparable across trials, but the pattern is similar.

Common Side Effects (Both)

Nausea — the most common
Diarrhea
Constipation
Stomach pain or cramping
Vomiting (less common)
Decreased appetite

Side effects are usually worst in the first few weeks and when your dose increases. Most people find symptoms improve over 4-8 weeks as the body adjusts.

What Differs

Foundayo is a daily dose, so GI effects may be more steady-state rather than spiking after a weekly injection
Zepbound is a weekly injection, so some people notice a spike in nausea or GI issues on injection day that eases by mid-week
Individual reactions vary — some people tolerate one better than the other for reasons that are not fully understood

Boxed Warning (Both)

Both Foundayo and Zepbound carry the same class boxed warning about thyroid tumors seen in rodent studies. The risk in humans is not known. You should not take either medication if you or anyone in your family has a history of:

Medullary thyroid carcinoma
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

For tips on managing side effects, see our GLP-1 side effects guide.

Cost and Coverage

List prices are nearly identical:

Feature	Foundayo	Zepbound
List price	~$1,050/month	~$1,060/month
Savings card (commercial insurance)	As little as $25/month	As little as $25/month
Medicare	Limited coverage expanding	Limited coverage expanding
Cash pay / no insurance	Check pharmacy discount programs	Check pharmacy discount programs

Your actual cost depends on your insurance plan. Key factors:

Is the drug on your formulary? Some plans cover one but not the other
What tier is it? This affects your copay or coinsurance
Is prior authorization required? This can delay your start by days or weeks
Does your plan exclude weight loss medications? Some do

Both Eli Lilly savings programs are for commercially insured patients only. They do not work with Medicare or Medicaid.

Before starting either medication, call your insurance and ask about coverage for both. If only one is covered, that may decide the question for you.

For a full cost breakdown, see our Zepbound cost guide and Zepbound savings card guide.

Who Might Prefer Foundayo?

Foundayo could be the better fit if you:

Hate needles — this is the number one reason people choose Foundayo
Want the simplest routine — one pill, any time, no food or water rules
Could not tolerate Rybelsus food restrictions — Foundayo has none of the empty-stomach, wait-30-minutes requirements
Prefer daily dosing — some people find daily habits easier to maintain than weekly ones
Want a newer option with expanding insurance coverage — Foundayo was approved April 2026 and coverage is growing

Foundayo's weight loss results (~11% average) are solid but lower than Zepbound's in separate trials. If maximum weight loss is your top priority, this may matter. See our Foundayo guide for the full breakdown.

Who Might Prefer Zepbound?

Zepbound could be the better fit if you:

Want the strongest weight loss data available — ~20% average in its trials, the highest of any currently approved weight loss medication
Prefer weekly dosing — one shot per week instead of a daily pill
Are comfortable with injections — the needle is small and most people say it hurts less than expected
Want a longer track record — Zepbound has been FDA-approved since November 2023
Already use injections — if you are switching from Wegovy or Ozempic, the injection routine is familiar

Zepbound does require handling, storing, and disposing of needles. It also needs refrigeration. See our GLP-1 storage guide and injection supplies guide for help with that.

For the full pill-vs-injection tradeoff across all GLP-1s, see Wegovy pill vs injection and our GLP-1 pills guide.

Can You Switch Between Them?

Yes, switching is possible, but there are important things to know:

You cannot take both at the same time. They work on overlapping pathways and combining them would increase side effect risk without proven benefit.
If you switch, you start at the lowest dose of the new medication. You do not carry over your dose from the previous drug.
Talk to your doctor before switching. They will help you plan the timing, manage side effects, and set realistic expectations.

Common reasons people switch:

Not getting enough weight loss on one medication
Side effects too difficult on one medication
Insurance coverage changes
Wanting to try a different route (pill to injection or vice versa)
Needle fatigue (switching from Zepbound to Foundayo)
Wanting stronger results (switching from Foundayo to Zepbound)

For more on switching GLP-1s, see our switching GLP-1 medications guide.

Questions to Ask Your Prescriber

Is Foundayo or Zepbound a better fit for my health history and weight loss goals?
Does my insurance cover one, both, or neither?
What dose would I start at, and how quickly would it increase?
What side effects should I watch for, and how do I manage them?
Can I switch later if the first option does not work well?
What happens if I miss a dose — how much does that set me back?
Are there any reasons I should avoid one of these specifically?

FAQ

Is Foundayo as strong as Zepbound?

No head-to-head trial exists, so nobody can say for certain. In separate trials, Zepbound showed ~20% average weight loss and Foundayo showed ~11%. These came from different studies with different patients. Zepbound targets two hormones (GLP-1 and GIP); Foundayo targets one (GLP-1). That may explain the difference, but you cannot directly compare cross-trial numbers.

Is Foundayo made by Eli Lilly?

Yes. Both Foundayo and Zepbound are made by Eli Lilly. They are different drugs with different active ingredients — orforglipron (Foundayo) and tirzepatide (Zepbound).

Can I switch from Zepbound to Foundayo?

Switching is possible, but talk to your doctor first. You cannot take both at the same time. If you switch, you will start at the lowest dose of the new medication. Your doctor will help you plan the transition and manage any side effects.

Which is cheaper, Foundayo or Zepbound?

Both have similar list prices — roughly $1,050-1,060/month before insurance. Your actual cost depends on your insurance plan and whether you qualify for manufacturer savings programs. Foundayo's savings program may bring the cost to as little as $25/month for eligible commercially insured patients. Zepbound has a similar savings card. Check your formulary for both.

The Bottom Line

Foundayo and Zepbound come from the same manufacturer but solve different problems. Foundayo gives you a daily GLP-1 pill with no food rules and no needles. Zepbound gives you the strongest average weight loss data of any approved medication, but it requires a weekly injection.

The real choice is not about which drug is "better." It is about what matters most to you:

If convenience and needle avoidance are your top priorities, Foundayo is worth asking your doctor about
If maximum weight loss is your top priority and you can handle injections, Zepbound has the stronger data
If cost decides it, check your insurance coverage for both before you choose

Both are legitimate options. Neither is wrong. The best medication is the one you can stick with consistently and that your insurance helps you afford.

This article is for informational purposes only and does not constitute medical advice. Talk to your healthcare provider before starting or changing any medication. Individual results vary. No head-to-head trial between Foundayo and Zepbound exists; all weight loss comparisons across these drugs are based on separate clinical trials and are not direct comparisons.